Patient Safety First!

How to Effectively Reduce Human Papillomavirus (HPV) Cross-Contamination Risk in Ultrasound Examinations

Fertility Conference Webinar

How to Effectively Reduce Human Papillomavirus (HPV) Cross-Contamination Risk in Ultrasound

Speakers: Dr Craig Meyers, World Renowned Expert in HPV Research, Professor of Microbiology and Immunology, Penn State College of Medicines & Dr David Weber, Professor of Medicine, Pediatrics, Epidemiology Associate Chief Medical Officer, UNC Hospitals Medical Director, Hospital Epidemiology

Host: Glen Ewing, Director, Germitec UK    

Synopsis: Dr David Weber will provide a research overview on vaginal ultrasound probe contamination despite the use of probe covers and Low-Level Disinfection. Dr Craig Meyers will then give his expertise in HPV research. He was the first lab to develop a technique to grow natural High-Risk HPV that causes 90% of cervical cancer and other anogenital cancers. He will discuss how it has been applied in product research to ensure US probe reprocessing effectively kills the virus.

Q&A Discussion topics

What is the process for a manufacturer to have their medical device tested against HPV, and what is the time frame?

  • “Need to contact the company directly to find out if the medical device has been HPV tested. As not all tests get published.”
  • “We discuss with the company test protocols and controls when designing the HPV study. The test outcomes take about four weeks.”

Cervical cancer incidence – Key Stats.

  • About 351,720 new cervical cancer cases are diagnosed annually in Asia (estimations for 2020).
  • Cervical cancer ranks* as the 4th leading cause of female cancer in Asia.
  • Cervical cancer is the 3rd most common female cancer in women aged 15 to 44 years in Asia

is leading the way in High Level Disinfection (HLD)

Chronos® automated UV-C High Level Disinfection (HLD) system is proven to kill native human papillomavirus (HPV) both in vitro and in clinical use.2-3

Chronos HPV tested

What Next!

Watch The Next Webinar

Click Here

First In-Use Study on Human Papillomavirus (HPV) Conducted in a Clinical Environment

Click Here

  1. Meyers J, Ryndock E, Conway MJ, Meyers C, Robison R. Susceptibility of high-risk human papillomavirus type 16 to clinical disinfectants. J Antimicrob Chemother. 2014;69(6):1546-50.
  2. Meyers C, Milici J, Robison R (2017) UVC radiation as an effective disinfectant method to inactivate human papillomaviruses. PLoS ONE 12 (10): e0187377.
  3. Maxime Pichon, Karine LebailCarval, Geneviève Billaud, Bruno Lina, Pascal Gaucherand and Yahia Mekki (2019) Decontamination of Intravaginal Probes Infected by Human Papillomavirus (HPV) Using UV-C Decontamination System. J. Clin. Med, 8, 1776; doi:10.3390/jcm8111776.
  4. Johnson. S. et al.(2013) Evaluation of a Hydrogen Peroxide-Based System for High-Level
    Disinfection of Vaginal Ultrasound Probes, Journal of Ultrasound Medicine, 321799-804,
  5. Meyers C, et al. (2020). The ability of two chlorine dioxide chemistries to inactivate human papillomavirus-contaminated endocavitary ultrasound probes and nasendoscopes. doi:10.1002/jmv.25666. Epub 2020 Feb 4. PMID: 31919857; PMCID: PMC7497195.
  6. C. Kyriacou, et al (2021) Time effectiveness and convenience of transvaginal ultrasound probe disinfection using ultraviolet vs chlorine dioxide multistep wipe system: prospective survey study.
Scroll to Top